Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "stations"

40 News Found

CoE Space Tech Foundation to host webinar on scaling bio research through space stations
Biotech | April 16, 2026

CoE Space Tech Foundation to host webinar on scaling bio research through space stations

Discussions will focus on how private space stations can improve access, repeatability and commercial feasibility for advanced biotech experiments


Hyderabad gets new 'Oval' fertility hub
News | June 02, 2026

Hyderabad gets new 'Oval' fertility hub

Fertility platform launches flagship clinic with advanced IVF tech


EMA backs conditional EU nod for Vijoice in rare life-threatening overgrowth disorder PROS
News | May 26, 2026

EMA backs conditional EU nod for Vijoice in rare life-threatening overgrowth disorder PROS

The company is expected to conduct further studies to confirm the long-term efficacy and safety of Vijoice in both adult and paediatric patients


Dr. Jitendra Singh calls for stronger research ecosystem
Policy | May 11, 2026

Dr. Jitendra Singh calls for stronger research ecosystem

The Union Minister reviewed DST-supported SATHI-BHU facility


Merck KGaA launches Phase 3 push for lupus skin disease with enpatoran trials
News | May 01, 2026

Merck KGaA launches Phase 3 push for lupus skin disease with enpatoran trials

The trials -- ELOWEN-1 and ELOWEN-2 -- are designed to evaluate the drug in people living with lupus who experience active skin manifestations


Experts call for precision diagnosis and standardised neonatal protocols
Hospitals | April 15, 2026

Experts call for precision diagnosis and standardised neonatal protocols

The perinatology CME at Navi Mumbai brought together more than 100 obstetricians, pediatricians, and neonatologists


Investigational therapy efzimfotase alfa shows promising Phase III results in rare bone disease
Clinical Trials | April 01, 2026

Investigational therapy efzimfotase alfa shows promising Phase III results in rare bone disease

Efzimfotase alfa is an investigational enzyme replacement therapy designed to reduce injection volume


Sanofi’s Venglustat shows breakthrough results in rare neurological Gaucher disease
Clinical Trials | February 04, 2026

Sanofi’s Venglustat shows breakthrough results in rare neurological Gaucher disease

Venglustat, a glucosylceramide synthase inhibitor (GCSi), works by reducing the abnormal buildup of sugar-and-fat molecules in cells and organs


EU green light to IntraBio’s AQNEURSA for rare neurological disease Niemann-Pick Type C
News | January 28, 2026

EU green light to IntraBio’s AQNEURSA for rare neurological disease Niemann-Pick Type C

The approval is grounded in data from a Phase III randomized, double-blind, placebo-controlled, crossover study in NPC patients


GRIN Therapeutics launches global Phase 3 trial for groundbreaking GRIN-NDD therapy
Clinical Trials | January 14, 2026

GRIN Therapeutics launches global Phase 3 trial for groundbreaking GRIN-NDD therapy

GRIN-NDD is one of the most complex neurodevelopmental disorders with limited treatment options today